View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/HRSA | RIN: 0906-AB02 | Publication ID: Spring 2017 |
Title: Definition of Human Organ Under Section 301 of the National Organ Transplant Act of 1984 | |
Abstract:
This final rule clarifies that peripheral blood stem cells are included in the definition of bone marrow under section 301 of the National Organ Transplantation Act of 1984, as amended and codified in 42 U.S.C. 274e. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: Not Yet Determined (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: Pub. L. 109-129 Stem Cell Therapeutic and Research Act of 2005, as amended in 2010 by Pub. L. 111-264 |
Legal Deadline:
|
||||||||||||
Overall Description of Deadline: On December 18, 2015, Public Law 114-104 was enacted and required the Secretary to issue a determination no later than December 18, 2016, as to whether peripheral blood stem cells and umbilical cord blood are "human organs" subject to NOTA section 301. |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Undetermined |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: No | |
Agency Contact: Dr. James Bowman Medical Director, Division of Transplantation Department of Health and Human Services Health Resources and Services Administration 5600 Fishers Lane, Room 12C-06, Rockville, MD 20857 Phone:301 443-4861 |